FDA Xigris Efficacy Analysis Suggests APACHE II Test Can Guide Therapy
Executive Summary
An FDA analysis of Lilly's Xigris Phase III efficacy data suggests that the APACHE II sepsis scale may be a useful guide for identifying candidates for therapy.